Latest Breaking News On - Bridgebio pharma inc - Page 4 : comparemela.com

BridgeBio Pharma (NASDAQ:BBIO) PT Lowered to $43 00

BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) had its target price reduced by research analysts at HC Wainwright from $47.00 to $43.00 in a research note issued to investors on Monday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s target price indicates a potential upside of 46.86% from the […]

Bio pharmaRaymond jamesBridgebio pharmaRandalw scottBridgebio pharma incInvestment advisors incHealthcare of ontario pension plan trust fundEntrypoint capitalCantor fitzgeraldAssetmark incGet free reportBio pharma trading downDirector randalPoint capitalOntario pension plan trust fundBridgebio pharma daily

BridgeBio Pharma, Inc (NASDAQ:BBIO) Sees Large Growth in Short Interest

BridgeBio Pharma, Inc. (NASDAQ:BBIO – Get Free Report) saw a large growth in short interest during the month of April. As of April 30th, there was short interest totalling 16,230,000 shares, a growth of 7.7% from the April 15th total of 15,070,000 shares. Currently, 11.5% of the company’s stock are sold short. Based on an […]

United statesBridgebio pharmaRandalw scottRaymond jamesBio pharmaBridgebio pharma incSecurities exchange commissionPricet rowe associates incComerica bankJpmorgan chase coJanus henderson groupGet free reportBio pharma trading downDirector randalExchange commissionState teachers retirement system

BridgeBio Pharma (NASDAQ:BBIO) Upgraded to Strong-Buy by Evercore ISI

BridgeBio Pharma (NASDAQ:BBIO) Upgraded to Strong-Buy by Evercore ISI
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Bridgebio pharmaRandalw scottRaymond jamesBio pharmaAssetmark incEntrypoint capitalHealthcare of ontario pension plan trust fundInvestment advisors incBridgebio pharma incGet free reportDirector randalPoint capitalOntario pension plan trust fundBridgebio pharma daily

BridgeBio Pharma s Options: A Look at What the Big Money is Thinking - BridgeBio Pharma (NASDAQ:BBIO)

Bio pharmaBridgebio pharma incBridgebio pharmaOpen interestBio pharma option activity analysisOptions spottedBio pharma incGenetic dermatologyAnalyst ratingsBenzinga pro

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Vikram baliBridgebio pharma incBio pharma incBio pharmaEquity planNasdaq listing ruleBridgebio pharmaBio contact